Latest

Market news by symbol, source, and language

20 stories
modular_finance

Invitation to the Presentation of Albert's Interim Report for January-June 2026

eEducation Albert AB (publ) will publish its interim report for January-June 2026 on 28 July at 07:30. On the same day at 09:15, there will be a presentation of the report, which can be followed via webcast.From Albert, CEO Fredrik Bengtsson and CFO Erik Bergelin will participate. The presentation…

MFN by Modular Finance en
ETFsStocksSE

REG - Amundi SA Prologis, Inc. - Form 8.3 - Prologis, Inc

RNS Number : 6316N Amundi SA 23 July 2026  FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCL…

London Stock Exchange en
StocksUS
globenewswire

FREELANDER Confirms September Abu Dhabi Brand Launch at Goodwood Festival of Speed, Marking the Next Step in Global Expansion

GOODWOOD, United Kingdom, July 23, 2026 (GLOBE NEWSWIRE) -- During the 2026 Goodwood Festival of Speed, British premium brand FREELANDER announced the UAE (United Arab Emirates) as its first international market at an industry exchange event hosted by the Abu Dhabi Investment Office (ADIO) at The O…

GlobeNewswire en
StocksGB

REG - Amundi SA SEGRO PLC - Form 8.3 - SEGRO plc

RNS Number : 6315N Amundi SA 23 July 2026  FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCL…

London Stock Exchange en
StocksGB
tradingview

ConnectOne Reports Q2 2026: Net Income $40.2M, NIM 3.42%, Tangible BV $24.66

ConnectOne reported second-quarter 2026 net income available to common stockholders of $40.2 million (diluted EPS $0.80), up from $36.3 million in Q1 2026 and a loss in Q2 2025. The company highlighted sequential improvement driven by a $4.8 million increase in net interest income and NIM expansion…

TradingView en
StocksUS
tradingview

Incannex Commences Screening in Phase 2 DReAMzz Study of IHL-42X for OSA

Incannex commenced participant screening in its DReAMzz Phase 2 dose confirmation study of IHL-42X, advancing the program toward Phase III.Key Highlights:Original SEC Filing: Incannex Healthcare Inc. [ IXHL ] - 8-K - Jul. 23, 2026This is an AI-powered summary. It may contain inaccuracies. Consider…

TradingView en
StocksUS